Type 2 diabetes and obesity have characteristics of inflammatory conditions with increased blood levels of pro-inflammatory cytokines, such as interleukin (IL)-6, IL-1 and TNF-α [42], which attenuate insulin receptor signaling [43]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.